Health Canada Authorised Rapid Test
The COVID-19 antigen rapid test device is a lateral flow in-vitro immunoassay intended to be used for the qualitative detection of the SARS-CoV-2 viral nucleoprotein. This device will detect both viable and nonviable virus in both nasopharyngeal and oropharyngeal secretions.
This test had been authorized for point of care use by Health Canada and is available for immediate dispatch
MediGuard Systems of Canada is an Authorised distributor of the Assuretech Rapid Antigen test.
Support documentation and details available on request
